Literature DB >> 17136480

Osteopontin and cardiovascular system.

Hiroshi Okamoto1.   

Abstract

A matricellular protein, osteopontin (OPN), is expressed in response to mechanical stress and similar stimuli in the heart, integrates the inter-ECM signal transduction network of component cells, and maintains efficient contractility through quantitative and qualitative control of extracellular matrix (ECM) proteins. In particular, OPN is re-expressed in the process of tissue damage; combines with other cell growth factors, cytokines, chemokines, and proteases as a cytokine itself or as an adhesion molecule; and controls the differentiation and growth of cells involved in restoration of tissues by controlling inter-cellular signal transduction and production of ECM proteins through regulation of expression levels and activity. A study using mice lacking a functional OPN gene indicated that tissue restoration fails and collagen deposition is inhibited through matrix metalloproteinases (MMPs) in mice lacking OPN. Thus, while OPN accelerates the cardiovascular remodeling process, it also regulates the balance of various inter-cellular activities. In addition, OPN not only promotes arteriosclerosis but is also closely associated with angiogenesis. With the roles of OPN expected to be clinically elucidated, the clinical use of OPN for control of cardiovascular remodeling may be feasible. Points (1) Osteopontin (OPN) efficiently propagates contraction in the heart as a matricellular protein and thereby controls ECM proteins both quantitatively and qualitatively. (2) The quantitative and qualitative control of ECM proteins is involved in interaction with OPN receptors including those of the integrin family, CD44, and others. (3) OPN promotes myocardial remodeling through TGFbeta and MMPs. (4) OPN not only promotes arteriosclerosis but is also closely associated with arteriosteogenesis. (5) In animals lacking OPN, tissue remodeling process is inhibited, especially in terms of fibrosis after myocardial infarction. (6) While the significance of OPN as an immune system molecule is still unclear in detail, the significance of OPN in the regenerative immune system has begun to be determined.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17136480     DOI: 10.1007/s11010-006-9368-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.842


  36 in total

1.  Myocardial osteopontin expression is associated with collagen fibrillogenesis in human dilated cardiomyopathy.

Authors:  Mamoru Satoh; Motoyuki Nakamura; Tomonari Akatsu; Yudai Shimoda; Ikuo Segawa; Katsuhiko Hiramori
Journal:  Eur J Heart Fail       Date:  2005-08       Impact factor: 15.534

2.  Detection of osteopontin in calcified human aortic valves.

Authors:  E R Mohler; L P Adam; P McClelland; L Graham; D R Hathaway
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-03       Impact factor: 8.311

3.  The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease.

Authors:  D Chabas; S E Baranzini; D Mitchell; C C Bernard; S R Rittling; D T Denhardt; R A Sobel; C Lock; M Karpuj; R Pedotti; R Heller; J R Oksenberg; L Steinman
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

4.  Osteopontin as a potential diagnostic biomarker for ovarian cancer.

Authors:  Jae-Hoon Kim; Steven J Skates; Toshimitsu Uede; Kwong-kwok Wong; John O Schorge; Colleen M Feltmate; Ross S Berkowitz; Daniel W Cramer; Samuel C Mok
Journal:  JAMA       Date:  2002-04-03       Impact factor: 56.272

5.  Osteopontin modulates myocardial hypertrophy in response to chronic pressure overload in mice.

Authors:  Zhonglin Xie; Mahipal Singh; Krishna Singh
Journal:  Hypertension       Date:  2004-11-08       Impact factor: 10.190

6.  Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction.

Authors:  N Ashizawa; K Graf; Y S Do; T Nunohiro; C M Giachelli; W P Meehan; T L Tuan; W A Hsueh
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

7.  Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions.

Authors:  J W Xuan; C Hota; Y Shigeyama; J A D'Errico; M J Somerman; A F Chambers
Journal:  J Cell Biochem       Date:  1995-04       Impact factor: 4.429

8.  Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice.

Authors:  Yutaka Matsui; Susan R Rittling; Hiroshi Okamoto; Manabu Inobe; Nan Jia; Toshihiro Shimizu; Masatoshi Akino; Takeshi Sugawara; Junko Morimoto; Chiemi Kimura; Shigeyuki Kon; David Denhardt; Akira Kitabatake; Toshimitsu Uede
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-05-01       Impact factor: 8.311

9.  Multiple forms of SppI (secreted phosphoprotein, osteopontin) synthesized by normal and transformed rat bone cell populations: regulation by TGF-beta.

Authors:  T Kubota; Q Zhang; J L Wrana; R Ber; J E Aubin; W T Butler; J Sodek
Journal:  Biochem Biophys Res Commun       Date:  1989-08-15       Impact factor: 3.575

Review 10.  Osteopontin: a protein with diverse functions.

Authors:  D T Denhardt; X Guo
Journal:  FASEB J       Date:  1993-12       Impact factor: 5.191

View more
  38 in total

Review 1.  Endogenous migration modulators as parent compounds for the development of novel cardiovascular and anti-inflammatory drugs.

Authors:  Wolfgang Poller; Madlen Rother; Carsten Skurk; Carmen Scheibenbogen
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation.

Authors:  Christopher J Wingard; Dianne M Walters; Brook L Cathey; Susana C Hilderbrand; Pranita Katwa; Sijie Lin; Pu Chun Ke; Ramakrishna Podila; Apparao Rao; Robert M Lust; Jared M Brown
Journal:  Nanotoxicology       Date:  2010-11-03       Impact factor: 5.913

3.  Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure.

Authors:  Michael R Zile; Stacia M Desantis; Catalin F Baicu; Robert E Stroud; Sheila B Thompson; Catherine D McClure; Shannon M Mehurg; Francis G Spinale
Journal:  Circ Heart Fail       Date:  2011-02-24       Impact factor: 8.790

4.  Elevated expression of activated Na(+)/H(+) exchanger protein induces hypertrophy in isolated rat neonatal ventricular cardiomyocytes.

Authors:  Fatima Mraiche; Larry Fliegel
Journal:  Mol Cell Biochem       Date:  2011-07-01       Impact factor: 3.396

5.  Reverse remodeling and recovery from cachexia in rats with aldosteronism.

Authors:  Yaser Cheema; Wenyuan Zhao; Tieqiang Zhao; M Usman Khan; Kelly D Green; Robert A Ahokas; Ivan C Gerling; Syamal K Bhattacharya; Karl T Weber
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-22       Impact factor: 4.733

6.  Differential coupling of Arg- and Gly389 polymorphic forms of the beta1-adrenergic receptor leads to pathogenic cardiac gene regulatory programs.

Authors:  Steven M Swift; Brigitte R Gaume; Kersten M Small; Bruce J Aronow; Stephen B Liggett
Journal:  Physiol Genomics       Date:  2008-07-29       Impact factor: 3.107

7.  Meta-analysis and profiling of cardiac expression modules.

Authors:  Uri David Akavia; Dafna Benayahu
Journal:  Physiol Genomics       Date:  2008-09-09       Impact factor: 3.107

8.  Extracellular matrix remodelling in myocardial hypertrophy and failure : focus on osteopontin.

Authors:  Pietro Francia; Arianna Uccellini; Alessandra Frattari; Anna Modestino; Agnese Ricotta; Cristina Balla; Ludovica Scialla; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-01-03

9.  Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta.

Authors:  Sylvia A Vetrone; Encarnacion Montecino-Rodriguez; Elena Kudryashova; Irina Kramerova; Eric P Hoffman; Scot D Liu; M Carrie Miceli; Melissa J Spencer
Journal:  J Clin Invest       Date:  2009-05-18       Impact factor: 14.808

10.  The Dietary Supplement Protandim Decreases Plasma Osteopontin and Improves Markers of Oxidative Stress in Muscular Dystrophy Mdx Mice.

Authors:  Muhammad Muddasir Qureshi; Warren C McClure; Nicole L Arevalo; Rick E Rabon; Benjamin Mohr; Swapan K Bose; Joe M McCord; Brian S Tseng
Journal:  J Diet Suppl       Date:  2010-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.